246 related articles for article (PubMed ID: 19089939)
1. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
Hillegass W
Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
[No Abstract] [Full Text] [Related]
2. PCI versus CABG for multivessel coronary disease in diabetics.
Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
[TBL] [Abstract][Full Text] [Related]
3. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
[TBL] [Abstract][Full Text] [Related]
4. Multivessel disease in diabetics: does DES level the field?
Hillegass W
Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
[No Abstract] [Full Text] [Related]
5. Does prior PCI influence the clinical outcome of CABG?
Taggart DP
EuroIntervention; 2009 May; 5 Suppl D():D21-4. PubMed ID: 19736065
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
Morrison DA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
[No Abstract] [Full Text] [Related]
7. The SYNTAX score in practice: an aid for patient selection for complex PCI.
Feldman T
Catheter Cardiovasc Interv; 2009 Apr; 73(5):618-9. PubMed ID: 19309708
[No Abstract] [Full Text] [Related]
8. Trifurcation left main coronary artery percutaneous revascularization--pushing catheters and envelopes.
Moliterno DJ
Catheter Cardiovasc Interv; 2009 Jan; 73(1):32-3. PubMed ID: 19089933
[No Abstract] [Full Text] [Related]
9. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
Sobel BE
Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
[TBL] [Abstract][Full Text] [Related]
10. Stenting the coronaries and bypassing the evidence in patients with multivessel coronary artery disease: time to set the record straight.
Zingone B
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):362-70. PubMed ID: 17443104
[No Abstract] [Full Text] [Related]
11. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting stents or drug-eluting conduits for multivessel disease?
Alfieri O; Maisano F; Benussi S; Toracca L; Castiglioni A
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):359-61. PubMed ID: 17443103
[No Abstract] [Full Text] [Related]
13. Stenting unprotected left main: the outcome is not always favorable.
Colombo A
Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
[No Abstract] [Full Text] [Related]
14. CABG or PCI: which is better? Bypass or angioplasty with stent? For multivessel disease, some say surgery is the superior treatment.
Health News; 2006 May; 12(5):8-10. PubMed ID: 16685751
[No Abstract] [Full Text] [Related]
15. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
[TBL] [Abstract][Full Text] [Related]
16. "Stick the landing," for optimal ostial placement of stents.
Morrison DA
Catheter Cardiovasc Interv; 2009 May; 73(6):769-70. PubMed ID: 19367630
[No Abstract] [Full Text] [Related]
17. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
[TBL] [Abstract][Full Text] [Related]
18. The value of clinical wisdom in randomised studies, real-world registries and new hypotheses.
Bernardi G; Morocutti G; Spedicato L; Zanuttini D
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):313-7. PubMed ID: 17443094
[No Abstract] [Full Text] [Related]
19. Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective.
Soran O; Manchanda A; Schueler S
Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):666-71. PubMed ID: 19307243
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]